TP53 and cancer: This study provides an insight into the integrated DNMT1–RUNX3 signaling by taking into account various cancer-related significant upstream and downstream regulators (such as p21, c-myc, p53, and MDM2) and presents the DNMT1–RUNX3 signaling cascades as one consolidated network.